Finally, the large-scale long-term albumin administration in decompensated cirrhosis (ANSWER) trial showed improved outcomes for patients treated with weekly albumin infusions, including a reduction in spontaneous bacterial peritonitis (SBP) and non-SBP infections (13). This evidence concerns the gene ALB and Cirrhosis.